Standard Biotools | FLDM - Operating Expenses


Standard Biotools reported $30.56M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Illumina USD 899M 47M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Nikon Corporation JPY 202.07B 67.73B Mar/2026
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Revvity USD 603.55M 24.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sony JPY 2.36T 443.83B Jun/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Waters USD 527M 592M Jun/2026